Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nagler

Showing results (1-10 of 474) with videos related to

Pageof 48
Sort By:
Bulletin on Narcotics|January 1, 1987
The Council of Europe Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (the Pompidou Group)N A Nagler
Harefuah|October 1, 1984
[The preleukemia syndrome--morphologic and biologic features]A Nagler, I Tatarsky
The Cancer Journal From Scientific American|February 11, 1998
Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplantsS Slavin, A Nagler
Leukemia|December 26, 2001
Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulationsA Shimoni, A Nagler
Bone Marrow Transplantation|October 1, 1996
Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicityR Condiotti, A Nagler
Current Opinion in Oncology|April 1, 1991
New developments in bone marrow transplantationS Slavin, A Nagler
Bone Marrow Transplantation|August 1, 1996
Solitary pulmonary cholesteroloma, multiple xanthelasmas and lipemia retinalis complicating hypercholesterolemia after bone marrow transplantationA Toren, A Nagler
Harefuah|May 1, 1986
[Regulation of hemopoiesis and immunomodulation by 1,25-dihydroxyvitamin D3]A Nagler, S Pollack
Experimental Hematology|July 10, 1998
Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cellsR Condiotti, A Nagler
American Heart Journal|June 1, 1992
Recombinant interleukin-2 and recombinant interferon alpha immunotherapy cardiovascular toxicityD Schechter, A Nagler
Pageof 48

Showing results (1-10 of 474) with videos related to

Sort By:
Pageof 48
Bulletin on Narcotics|January 1, 1987
The Council of Europe Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (the Pompidou Group)N A Nagler
Harefuah|October 1, 1984
[The preleukemia syndrome--morphologic and biologic features]A Nagler, I Tatarsky
The Cancer Journal From Scientific American|February 11, 1998
Cytokine-mediated immunotherapy following autologous bone marrow transplantation in lymphoma and evidence of interleukin-2-induced immunomodulation in allogeneic transplantsS Slavin, A Nagler
Leukemia|December 26, 2001
Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulationsA Shimoni, A Nagler
Bone Marrow Transplantation|October 1, 1996
Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicityR Condiotti, A Nagler
Current Opinion in Oncology|April 1, 1991
New developments in bone marrow transplantationS Slavin, A Nagler
Bone Marrow Transplantation|August 1, 1996
Solitary pulmonary cholesteroloma, multiple xanthelasmas and lipemia retinalis complicating hypercholesterolemia after bone marrow transplantationA Toren, A Nagler
Harefuah|May 1, 1986
[Regulation of hemopoiesis and immunomodulation by 1,25-dihydroxyvitamin D3]A Nagler, S Pollack
Experimental Hematology|July 10, 1998
Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cellsR Condiotti, A Nagler
American Heart Journal|June 1, 1992
Recombinant interleukin-2 and recombinant interferon alpha immunotherapy cardiovascular toxicityD Schechter, A Nagler
Pageof 48